Sun Pharma to Acquire US-Listed Organon in $12 Billion Deal

Sun Pharmaceutical Industries Ltd. agreed to acquire New York-listed women’s health-care company Organon & Co., in what is likely to be one of the biggest India outbound deals in years.
Source
Bloomberg Markets
Opens original article in a new tab


